INTERPHEX Rescheduled for 2021 Due to COVID-19

Article

The event will be rescheduled for April 20–22, 2021 at the Javits Center in New York City.

Reed Exhibitions announced on April 30, 2020 that it was rescheduling its pharmaceutical industry event, INTERPHEX - previously postponed to July 15–17 at the Javits Center in New York City - to April 20–22, 2021 at the same venue due to the continuing spread of COVID-19.

“Our entire team is here to support all of our customers and partners and we are passionate about providing new options for us to come together, virtually throughout the summer and with smaller face-to-face interactions opportunities in the fall, when we can. Stay tuned for more information coming soon,” said Kate Scott, event director, INTERPHEX, in a press release.

The announcement comes days after INTERPHEX announced the launch of RECONNEX 365, an online resource that provides exhibitor expertise and technical know-how year-round.

“You will see even more tools, resources, and innovative solutions coming from the INTERPHEX team,” added Scott in the press release. “These will allow you to make new connections; meet leading suppliers; source technologies, products, and services; and learn from industry subject matter experts to enable you to find solutions to develop and manufacture cost-effective, quality therapeutics for the global population.”

Source: Reed Exhibitions

 

 

 

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content